CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Atlanta Lawmaker Pushes City To Study Psilocybin, Ketamine Treatments

A city councilmember in Atlanta has proposed a measure that could open the door for both psilocybin and ketamine treatments. The councilmember, Liliana Bakhtiari, believes that health plans for city workers should include the treatments, which research has shown to be effective in combating mental health disorders such as PTSD. “We should be offering our employees — and especially our first responders, who are expected to be superhuman — the same amount of grace and providing them with a tool set to essentially overcome this issue,” Bakhtiari said in an interview with Axios. Per Axios, the proposal “tasks the city’s HR department with studying the pros and cons of ketamine and psilocybin to treat mental health issues and whether the employee health plan could cover the treatments.” The outlet adds that “ketamine can be taken under the care of a psychiatrist” in Georgia, and that Bakhtiari “says she has used ketamine therapy to treat past trauma,” and that “some sessions can cost roughly $350 out of pocket.” As a councilmember, Bakhtiari has been a vocal champion of the treatment and drug reform. In 2022, Bakhtiari introduced a resolution that would have “formally request[ed] that police make it ‘the lowest law enforcement priority’ to investigate or arrest people for ‘planting, cultivating, purchasing, transporting, distributing, engaging in practices with, or possessing Entheogenic Plants, Fungi, and Spores or plant compounds,’” Marijuana Moment reported at the time. With a growing body of research on the efficacy of psychedelics as a mental health treatment, more lawmakers across the country have pushed for reform. Earlier this year in Vermont, lawmakers passed a measure to set up a working group to look into psychedelics and their application in therapy. Maryland Gov. Wes Moore signed a similar bill into law earlier this month. The measure will create the “Task Force on Responsible Use of Natural Psychedelic Substances,” a 17-member panel that will make recommendations designed to “[enable] broad, equitable, and affordable access to psychedelic substances.” The law requires the task force to make the recommendations “regarding any changes to State law, policies, and practices needed to create a program that enables broad, equitable, and affordable access to psychedelic substances; and requiring the Task Force to report its findings to the Governor and the General Assembly on or before July 31, 2025.” Meanwhile, a bill recently introduced in the New York Assembly would legalized psilcoybin service centers. The proposal would change the existing law “in relation to promoting the health and well-being of the citizens of the state of New York by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi.” Additionally, the bill would seat up the “Regulated Psilocybin Advisory Board,” comprised of 13 members who would be charged with studying laws and policies pertaining to psilocybin, and then provide recommendations to the state’s Department of Health. Per the text of the bill, the board would “develop a long-term strategic plan for ensuring that psilocybin services in the state will become and remain a safe, accessible and affordable therapeutic option, including in therapeutic and medical treatments, for all persons eighteen years of age and older for whom psilocybin services may be appropriate.” A study published earlier this year revealed that individuals with major depressive disorder experienced improvement in their symptoms following intravenous ketamine infusion therapy. The report, based on a clinical trial involving 75 patients across four sites in the United States, was published in the Journal of Affective Disorders. The patients “received 3 IV ketamine infusions over an 11-day period.”  “Key exclusion criteria were psychotic symptoms, significant substance abuse, unstable medical conditions, and any use of cannabis. Pre-existing antidepressant medication was maintained. Primary outcome was remission as measured by Montgomery-Asberg Depression Rating Scale (MADRS), with secondary outcome of 50 % reduction in Beck Suicide Scale score. Safety monitoring and varying durations of infusions were also key parameters,” the authors of the study wrote.  “The consistency of outcomes across 4 clinical sites and across multiple instruments, suggests high acute efficacy and safety of IV ketamine for serious depressive episodes. Duration of infusion did not alter outcomes,” the authors wrote in their conclusion.  “Meaningfully, 40 % of non-responders after a single infusion did reach remission subsequently, while only 20 % of non-responders after 2 infusions achieved remission, suggesting early response is suggestive for eventual remission. Our data on varying ketamine infusion duration adds novel insights into the clinical administration of this new treatment for refractory and severe patients. Our limitations included a lack of a control group, necessitating caution about conclusions of efficacy, balanced by the utility of reporting “real-world” outcomes across multiple clinical sites. We could also not separately analyze results for bipolar disorder due to small numbers. Together, the Bio-K clinical results are promising and provide significant sample sizes for forthcoming biological markers analyses.

https://hightimes.com/

2024 Farm Bill Amendment Would Ban Hemp-Derived THC Products

The U.S. House Committee on Agriculture recently released a 942-page draft of the 2024 Farm Bill, also called the Farm, Food, and National Security Act of 2024, on May 17. Currently the bill is projected to cost $1.5 trillion over a 10-year period. During a Farm Bill hearing on May 23, the committee passed an group of amendments en bloc, one of which would essentially prohibit all hemp-derived products. In its current form, the amendment would implement a ban on “all ingestible hemp products with any level of THC.” It would also redefine hemp to “only include naturally occurring, naturally derived, and non-intoxicating cannabinoids,” and remove cannabinoids “synthesized or manufactured outside of the plant” from the definition of legal hemp. The amendment was proposed by Illinois Rep. Mary Miller. “My amendment will close the loophole created in the 2018 Farm Bill that allows intoxicating hemp products like delta-8 to be sold,” Miller said on May 23. “These products are being marketed to children and sending hundreds of them to the hospital. We must stop teenagers and young children from being exposed to addictive and harmful drugs.” Some representatives expressed support for Miller’s amendment, but requested more information. Tennessee Rep. John Rose explained that more clarification is necessary to separate the “intentional and unintentional products” in the 2018 hemp definition. Virginia Rep. Abigail Spanberger added that she only seeks to make changes that would benefit farmers in her state. “Greater clarity is incredibly important, and particularly for fiber hemp producers, this amendment would make clear the valuable work that they do and make clear the viability of their product,” Spanberger added. However, many more legislators opposed the amendment, such as Indiana Rep. Jim Baird. He argued that since the 2018 Farm Bill was passed, many farmers have invested everything they had into farm businesses. “American farmers deserve the certainty afforded with the current definition of hemp. The proposed amendment arbitrarily changes the current congressionally written definition of hemp,” Baird said. While Miller’s amendment is an attempt to protect children, Rep. Derrick Van Orden argued that many Americans have embraced their hemp businesses as their livelihood in order to care for their families. “American farmers deserve the certainty afforded with the current definition of hemp,” said Van Orden. “The proposed amendment arbitrarily changes the current congressionally written definition of hemp.” Indiana Rep Zach Nunn also echoed this opinion, stating that he wants to work with his colleagues to protect kids from drugs, but the amendment “goes too far” by banning hemp grain and fiber industries. Many hemp organizations such as the independent nonprofit U.S. Hemp Roundtable immediately released statements regarding the  news. “We had been assured on several occasions by committee staff and the Chairman personally that they would not support any effort to kill the hemp industry,” the organization wrote about the en bloc amendment passage. “But unfortunately, the decision was made by the Chairman to use a procedural tactic to avoid a separate vote on the issue.  And that resulted in passage of a deeply flawed and deeply objectionable policy.” The Farm Bill and its amendments have been sent to the House floor for discussion, but the U.S. Hemp remains confident that it won’t pass. “Even if the House should pass the Farm Bill, the differences between House Republicans and Senate Democrats are considerable at this point,” the organization continued. “And even if the major issues dividing the parties are resolved, we continue to have many friends in both branches on both sides of the aisle who will work with us to defeat this hemp-killing language.” Indigenous Cannabis Industry Association founder Rob Pero (also called Bad River) also published a statement expressing concern, especially for the unknown effects such an amendment would have on CBD products. “This would not only impact potentially impairing products like Delta-8 but would also extend to non-intoxicating CBD products with any quantifiable amount of THC” Pero stated. “Such a broad prohibition would effectively eliminate 90-95% of the hemp products market, jeopardizing the livelihoods of countless farmers, entrepreneurs, and Indigenous communities relying on the hemp industry for economic sustainability.” The National Cannabis Industry Association (NCIA) expressed its recommendations on how to best regulate intoxicating hemp products, as according to its paper, “Navigating the Future of Cannabinoid Regulation.” This includes regulating intoxicating THC hemp products in the same manner as cannabis or alcohol, increasing the THC percentage allowance in hemp products to 1% (up from 0.3%), and creating “reasonable” THC content limits per serving. “Congress has the opportunity to protect public health and support small businesses by enacting sensible regulations for cannabinoid products,” said NCIA CEO Aaron Smith.

https://hightimes.com/

Eaze Faces Foreclosure Amid Legal Challenges

Eaze—California’s largest cannabis delivery service, once valued at $700 million and backed by Snoop Dogg—now faces foreclosure. SFGate reports that it follows an ownership battle in court for the once-mighty delivery service that’s dragged on for over a year.  WeedWeek reports that the company defaulted on a loan issued by tech investor Jim Clark. Clark, who founded Netscape, among other entities, invested in Eaze and took over a role on the company’s board of directors since 2021. In August 2022, a shell company co-owned by him issued a $36.9 million loan to Eaze that gave Clark power to seize control of Eaze if it failed to meet monthly revenue requirements laid out by Clark’s company, according to a 2023 lawsuit filed by other Eaze investors. Clark currently is foreclosing on the company and demanding all collateral owned by Eaze, according to the court filing. Cory Azzalino, Eaze’s CEO, told SFGate that the foreclosure is the result of a dispute among the company’s investors. The investors believed they could be losing their equity rights to the company.  In another lawsuit, Clark allegedly misrepresented the company’s financial status to attract more investment in the company, but that lawsuit was dismissed by a San Francisco judge in November 2023. But Azzalino clarified that the foreclosure would not affect the company’s immediate operations and said Eaze is still in a “healthy financial position.” San Francisco-based Eaze launched in 2014 by Keith McCarty to deliver medical cannabis to patients across California. But two years later, as the company grew, McCarty stepped down from his position as CEO. Several spinoff companies launched such as EazeMD, a service that helps people get a recommendation for medical cannabis from a doctor, and Eaze Insights, a research company. Eaze Wellness, on the other hand, provides products infused with CBD. “As California’s largest legal cannabis marketplace, we bring enjoyment and convenience to our customers, break down barriers to access, and cultivate community in everything we do,” the company states. “With nearly 8 million cannabis deliveries to-date, we are committed to creating a more diverse and sustainable industry through our Momentum business accelerator, Social Equity Partners and Eaze Compassion Programs.” “Eaze’s mission is to deliver good with the goods,” the company states, describing its social equity values. “We believe the legal cannabis market can help address some of the biggest problems facing America and supports social and economic initiatives around key issues important to the cannabis community. Every day, we work to embody the values of increasing access, supporting patients, and addressing harm caused by the War on Drugs.  In 2019, Eaze had to scale back ambitions after projecting it would sell $1 billion worth of cannabis in 2020 to less than $500 million in gross transaction value. Unionization efforts have clashed with Eaze leadership. MJBizDaily reports that 500 of the company’s delivery drivers and depot employees in Los Angeles, Orange County, San Diego, and Northern California were ready to walk off the job after negotiations fell apart last March to secure the first labor contract between staffers and the San Francisco-based delivery company. Last April, nearly 600 workers at 11 depot locations owned by Eaze, a cannabis-delivery company in southern and northern California, threatened to strike over pay and conditions. United Food and Commercial Workers (UFCW) applauded the strike after members rejected Eaze’s final union contract offer. Former driver Ron Swallow and his co-workers unionized with near unanimous support in March 2023. “They cut our mileage rate. We’d been hired at 56 cents a mile and then they cut it to 42 cents,” Swallow told The Guardian. “That cost drivers $300 to $700 a month on average, depending on how much you drive and that was pretty annoying. It was also the first time in my whole life I’ve ever come to a job and then been told I was going to get paid less.” Swallow explain other issues he ran into while working for the company. “They wanted to offer us 45 cents and we of course said no to that because it didn’t get us back up to where we started out. We’re very united,” said Swallow. “When you join with a union, you just become the union, the people working become that and that is one of the coolest things that I’ve seen, drivers come together just being supportive of each other and our staff as well, because our staff is underpaid, too.” Eaze of Sacramento also joined the Teamsters. Last March, delivery drivers at Eaze in Sacramento voted unanimously to join Teamsters Local 150. California’s cannabis industry as a whole has hit some major hurdles. MedMen, the largest cannabis distributor in California once worth billions of dollars, declared bankruptcy last month. In addition, dispensary chains have faced similar clashes with union memes.

https://hightimes.com/

Majority of Texans Now Support Legalizing Pot for Adult Use

A statewide poll in Texas revealed that six out of 10 adults support legalizing cannabis in the state—the first time the poll has shown a solid majority. The issue of cannabis is gaining increasing bipartisan support, gaining support from states that typically vote blue or red. According to results from the 18th annual Texas Lyceum Poll, 60% of adult Texans say they support adult-use cannabis—representing a 14% jump from the last time the survey asked about marijuana in 2015. “Overall, 60% of Texas adults say that they support legalizing the use of marijuana in Texas, a 14 point increase since the question was last asked in 2015, when a majority of voters (50%) expressed opposition. Asked about expanding legal casino gambling in Texas, 57% of Texans said they would be supportive of expanded casino gambling, while 28% said they would be opposed.” The Dallas Morning News reports that only older adults, Republicans, and self-identified conservatives were divided on support for adult-use cannabis. Among Texans over the age of 65 and Republicans, 49% said they support legalization, and among those who identified as conservative, 46% were in support, and 31% of those polled said they oppose cannabis legislation. The questions weren’t always clear as to why people oppose legalizing cannabis. For instance, some simply want to decriminalize it instead: Among those who oppose legalization, 42% said that they would support decriminalizing possession of small amounts to a citation and fine. The poll also asked about numerous other topics such as politics, religion, housing, and space exploration. Gambling is also gaining support in Texas, according to the Texas Lyceum Poll. In November of this year, the Texas Lyceum will hold a conference on South Padre Island entitled, “Win, Lose or Draw: The Future of Marijuana and Gambling in the Lone Star State.” The state’s unique politics come into play when it comes to cannabis. Texans have voted Republican in every general election since 1976.  Some analysts believe that having a Bush on the ticket in every election from 1980 through 2004 (except 1996) helped cement Texas as a “reliably red state.” In 2020 however, that lead waned, and Donald Trump won the state by 6.5% over Joe Biden, the narrowest margin since 1996. But the demographics in Texas are changing quickly. Patients who are eligible can access low-level THC cannabis under the state’s compassionate use program, established in 2015. But it only allows certain physicians to prescribe low-THC products to patients with seizure disorders, multiple sclerosis, and other conditions. The Texas Legislature expanded the program’s eligibility to include patients with all forms of PTSD and cancer in 2021. Decriminalization attempts at the city level have faced opposition from state leaders. Last February, Texas Attorney General Ken Paxton filed lawsuits against five cities that have passed cannabis decriminalization measures. The lawsuit was filed against the cities of Austin, San Marcos, Killeen, Elgin, and Denton “for adopting amnesty and non-prosecution policies that violate Texas laws concerning marijuana possession and distribution,” according to the attorney general’s office. In 2022, the five cities enacted ordinances or civic policies that bar police officers from enforcing state laws prohibiting the possession or distribution of cannabis.  After filing the lawsuits, Paxton said that such policies are prohibited by the Texas Local Government Code, which bars municipal and county governments from adopting “a policy under which the entity will not fully enforce laws relating to drugs.” “I will not stand idly by as cities run by pro-crime extremists deliberately violate Texas law and promote the use of illicit drugs that harm our communities,” Paxton said in a statement on Wednesday. “This unconstitutional action by municipalities demonstrates why Texas must have a law to ‘follow the law.’ It’s quite simple: the legislature passes every law after a full debate on the issues, and we don’t allow cities the ability to create anarchy by picking and choosing the laws they enforce.” In 2022, Denton voters approved an ordinance to decriminalize cannabis, with 71% of voters in favor, but some officers and the mayor of Denton ignored the law anyways. High Times also reported on Texas cops who essentially ignored hemp laws in Texas and the 2018 Farm Bill and raided hemp sellers anyways. Currently, possession of up to two ounces of cannabis in most areas of Texas is a Class B misdemeanor and punishable by up to 180 days in jail and a fine of up to $2,000. Possession of over two ounces can result in up to a year in jail, and more than four ounces is a felony crime, with a mandatory minimum sentence of two years. Any amount of cannabis concentrate is considered a felony in Texas punishable with a minimum $10,000 fine and 180 days in jails. In addition, paraphernalia is also illegal and can result in a $500 fine.

https://hightimes.com/

Data Shows Growing Number of Native American Tribal Cannabis Business Owners

As more states continue to legalize adult-use cannabis, we’re witnessing a growing trend surrounding ownership of cannabis businesses — namely that Native American tribes are investing in cannabis with tribal-owned stores becoming increasingly more common in recent years. According to data published in MJBizDaily, the number of tribally owned retailers has grown by roughly 25% since January 2023. As of May 2024, there are 57 tribally owned dispensaries, both medical and adult-use, throughout nine states. With legal adult-use cannabis becoming more commonplace throughout the country, tribes are entering the industry to diversify their economies and boost revenue.  Though legal cannabis also carries unique benefits for tribes, as a way to assert their sovereignty and seize the first-to-market advantage in newly legal states, as explained by guest columnist Matthew Klas, a senior associate with Minneapolis-based national consulting firm KlasRobinson Q.E.D. specializing in economic development on tribal lands. There are 574 Native American tribes recognized by the U.S. government, with roughly 350 falling in the lower 48 states. Sovereign nations may have their own laws that differ from state laws, sometimes more restrictive — like cannabis sales and use bans even within states that have enacted recreational reform — or sometimes offering more leniency than state law. While many of the stores are on tribal lands, not all are. Tribes are currently operating businesses in nine states: California, Michigan, Minnesota, Nevada, New Mexico, New York, North Carolina, South Dakota and Washington.  The data found that the average size of tribal cannabis stores is about 4,300 square feet, ranging from stores with less than 1,000 square feet to complexes spanning more than 10,000.  Washington state has the most tribal retailers and the most tribes operating shops, at 23 stores operated by 18 tribes. Nevada is second, with 10 tribal stores owned by eight different tribes. Most of these tribally owned shops are located within markets with legal recreational cannabis, though there are exceptions. For example, there are two tribally owned dispensaries in South Dakota and one in North Carolina that currently offer medical cannabis exclusively.  The data does not include businesses owned by individual tribal members, rather than a tribal government. We can look at Minnesota to see how tribal business owners are able to get a jumpstart on a budding industry, as lawmakers in the state legalized adult-use cannabis last year but have yet to begin licensing retail establishments.  It’s unlikely that the marketplace will open until at least 2025, leaving a gap between legalization and the opening of the regulated market. However, tribal-owned dispensaries are helping to bridge that gap as two dispensaries owned by the Red Lake Nation and White Earth Nation are currently serving adult-use customers with plans to open additional facilities in the future. According to Minnesota’s recreational cannabis law, the governor can negotiate compacts with state tribes if they seek to take advantage of cannabis sales, but it also “acknowledges the sovereign right of Minnesota Tribal governments” to regulate their cannabis industries even without a compact. Red Lake and other tribes can also operate dispensaries outside of reservations through compacts negotiated with the governor’s administration. “We see this as a resource not only to reduce harm, but to also bring in resources to help our people recover,” said Red Lake Nation Tribal Secretary Sam Strong. The Mille Lacs Band of Ojibwe is also constructing a 50,000 square foot cannabis cultivation facility near Minneapolis, which is larger than any state-licensed grow operations, that will focus on seed-to-sale operations and could be a crucial part of the state’s recreational industry upon full launch. Similarly, New York has witnessed numerous delays in the launch of its recreational cannabis market, but three tribally owned stores have opened in the state since 2023. With Minnesota’s specific laws designed to leave room for tribal sovereignty, Klas says that the Minnesota market will be “particularly interesting” to watch in the future, adding that, “Minnesota could see some of the fastest growth of tribal cannabis businesses in the United States.” The full column can be found here.

https://hightimes.com/

The Hottest Legal THCA Snow Caps

Maybe you’ve been hearing about THCA Snow Caps aka THCA Snowballs, which are slowly becoming a very in-demand product on the hemp market, as more and more customers are gravitating toward high-potency flower products.  THCA snowcaps, also known as snowcaps, are named after their frosty appearance, and they are extremely potent, making them great for those who crave an extra-strong THCA kick. If you’re curious to know what THCA snowcaps can offer to hemp enthusiasts, stick around folks, because we’ll be explaining what they are, how they’re made, and how to grab the highest-quality snowballs that are out there today. And if you want to try THCA Snow Caps use our code HIGHTIMES25 for 25% off while being treated to fast and free shipping here.  First up, we want to shed light on exactly what THCA Snowcaps are.  We’re all familiar with THCA flower, which is hemp-derived flower buds that are bred carefully to produce a high concentration of THCA.  THCA, of course, is tetrahydrocannabinolic acid, aka delta 9’s raw form, which turns into delta 9 when it’s exposed to a specific temperature, which can be achieved through smoking, vaping, or cooking/baking with the flower buds. THCA flower is hugely popular because it’s chemically identical to weed, while being protected under federal law.  THCA snowballs take the concept to a new level, by coating each high-THCA flower bud in THCA diamond dust. THCA diamonds are purified/ THCA cannabinoid, which naturally takes on a crystalline form.  Odorless, colorless, and flavorless, THCA diamonds are pure THCA, meaning that their potency is high, and they, like the flower, actually provide delta 9 THC once heated. THCA diamond dust is the result of crushing the diamonds into a fine power.  By coating each bud in this powder, you get a flower bud that has an outstanding THCA concentration – up to 80%, in fact, while traditional flower buds rarely exceed 30%. THCA snow caps are used interchangeably with THCA flower buds.  You can smoke them, vape them, bake with them, or what have you, with no difference between how they’re utilized vs. standard flower.  And, they’re cultivated just like regular flower, since again, the only difference is that THCA snowcaps are rolled in diamond dust after the curing process is complete. With that being said, THCA Snow Caps, like THCA flower, can vary in terms of how they’re cultivated.  All THCA flower comes from industrial hemp, which can be grown indoors, outdoors, or in a greenhouse, with all kinds of different techniques used to ensure the best outcome of the flower buds themselves. Exotic THCA snowcaps come from exotic THCA flower buds, and this distinctive classification speaks to the exceptional quality and high THCA percentage that customers are in for.  In order to be considered exotic, THCA flower must have the following qualities: THCA snowcaps, therefore, are going to be a step above the rest, as this is the highest caliber of quality that you can find.  It should be pointed out that most exotic THCA flower is grown indoors, as it’s easier to control the outcome of the buds through manipulation of light, temperature, and so on, all of which play a major role in the development of the desirable cannabinoids and terpenes in the plant. Again, THCA Snowballs are a high-potency product, which means that they’re best for someone who already has a good THC tolerance.  Because THCA converts into delta 9 THC when flower is consumed, the high you can get from using snowballs is pretty intense.  For those who find that regular flower is too mild for them, that’s a good thing. Also, remember, THCA snowcaps offer tremendous value.  They’re so powerful that a little goes a long way, basically stretching out your supply so you can go longer between having to reup. You will see THCA snowcaps confused for THCA moonrocks pretty frequently, but these are ultimately two different products.  THCA moonrocks are THCA flower buds infused with THCA distillate and covered in kief, which is a full-spectrum powder that naturally falls off of the trichomes of the buds.  This is different from THCA snowcaps, which are more potent, as they’re covered in a thick layer of pure THCA diamond dust.   THCA Snow Caps are the next big thing on the hemp market, and Bloomz has you covered with outstanding, high-quality and well-crafted THCA Snowballs, combining the most exceptional flower with pure THCA diamonds for max potency and max satisfaction.   Bloomz has over 4,000 five-star customer reviews, over 100,000 loyal customers, fast and free shipping, 24/7 customer service, and best of all the strongest THCA Snow Caps on the market with flower above 30% potency. It  does not get much better than that! You will be able to enjoy boutique-level and indoor-grown THCA snowballs, available in 3.5g and 7g options, which are made using organically homegrown buds that’re already high in tetrahydrocannabinolic acid, rolled in Bloomz signature 99% pure THCA diamond dust.  The extravagant potency of these snowcaps means that you’re in for a high that’s out of this world.   Best of all you get to explore all 4 strains while finding satisfaction on a whole new level – 2 “standard” and 2 “exotic” strains. THCA Snowcaps are Indoor High Percentage THCA Flower covered in potent and pure THCA Isolate.  Ideal for connoisseurs seeking the highest quality and intensity, these THCA snowcaps deliver a powerful experience in every puff.  You can truly elevate your sessions with the purest, most potent THCA SnowCaps on the market. MAC is a 50/50 hybrid short for Miracle Alien Cookies, with roughly 24% THCA.  Its carefree high is legendary, offering a feeling of relief in the mind and body, as you stay calm yet uplifted throughout the experience.  It’s a dank strain with pungent notes of diesel, citrus, and earthiness. A cross between Pineapple Express and OG Kush, Pineapple OG is a superstar of a cultivar, with about 26% THCA, and a 70% sativa orientation.  It’s a sociable strain that can make you feel chatty, euphoric, and like all is right in the world, and can relax the body without sedating you. This is Exotic THCA Flower used with these snowcaps in order to create the strongest and best batches of farm-grown THCA Flower around.  Combined with pure THCA Isolate, this Snowcaps THCA Flower is the top choice on the hemp marketplace. Sour Diesel is a 90% sativa-dominant hybrid that’s legendary, with its powerful notes of diesel and sour lemons, and its ability to offer up a major boost in energy, chattiness, and creativity.   Mendo Purps is a 60/40 sativa-dominant hybrid with roughly 22% THC, known for its ability to give you fits of giggles, acting as the perfect social strain for when you want to partake with your friends.  Bloomz THCA Flower Offers High Potency for Maximum Satisfaction! Overall, if you’re looking to get as high as possible off of THCA Snowcaps , then you have found your new favorite flower brand: Bloomz. Here, you can explore 2 distinctive product lines, both offering high levels of THCA that you know and love.   Head on over to Bloomz and check out their selection, keeping in mind that their Gold Line Snowcaps delivers the highest THCA levels you will discover on the hemp marketplace today and don’t forget to use the code HIGHTIMES25 for 25% off while being treated to fast shipping so that you can take advantage of this THCA Snow Caps. To Buy Brand New THCA Snowcaps Click Here

https://hightimes.com/

Martha’s Vineyard Dispensary Sues To Allow Delivery of Cannabis From Massachusetts Mainland

Martha’s Vineyard is an island off the coast of Massachusetts that’s known for its 23 miles of scenic hills and beaches. It’s a popular destination for summer vacationers enjoying the quaint Victorian architecture, as of July 2021, it had one medical cannabis dispensary (Fine Fettle Dispensary) which until recently was also the only cannabis cultivator on the island, in addition to one adult-use only dispensary (Island Time) which opened in August 2021. The cost of living is high in Martha’s Vineyard, and for business owners, it’s expensive to transport goods from the mainland across the Vineyard Sound (aka the stretch of ocean that sits between Cape Cod, Massachusetts and Martha’s Vineyard). For cannabis businesses, it’s also federally illegal to have cannabis products delivered from the mainland. Recently, the owner of Island Time, Geoff Rose, filed a lawsuit against the Massachusetts Cannabis Control Commission (CCC) regarding a rule that bans him from transporting cannabis by boat from the mainland. “For more than 11 years, my efforts have centered on providing safe and responsible cannabis to local residents and visitors alike,” Rose explained to the Vineyard Gazette. “I’m hoping that the court will mandate the commission take immediate action to allow us to transport the product from the mainland.” He added that the rule puts a burden on him as a business owner, since he can only sell cannabis that he cultivates on the island. This rule was put in place because of state and federal regulations about cannabis being moved across water or through airspace. Rose’s lawsuit claims that Vineyard Sound is still within the state’s jurisdiction. Earlier in May, the other dispensary and sole owner of the island’s only cannabis production license, Fine Fettle Dispensary, announced that it would be shutting down operations. “Very sadly, we have had to make the decision to slow down and then ultimately shut down operations on the Vineyard,” Fine Fettle Dispensary president Benjamin Zachs said to the Vineyard Gazette. Up until now, Island Time obtained all of its cannabis products from Fine Fettle Dispensary. To bypass this new change, Rose inquired with the CCC about ordering cannabis from the mainland, but the CCC rejected the idea, stating the limitations of violating federal law. In March, Rose had cannabis delivered by boat anyway, and the products were delivered on a Steamship Authority ferry, which is run by the U.S. Coast Guard and falls under federal authority. The unnamed supplier that Rose worked with later received a warning. He was told not to sell the products delivered via ferry, but that order was later lifted, and Rose was able to sell out of all of the products. Last week, Rose officially closed his dispensary and told customers that he is unable to receive any new product. “We will reopen when we are able to source products from the mainland,” Rose wrote. “I am hopeful for a resolution soon that will result in more products, choices, and value for you, our valued customer.”  Through the lawsuit, Rose is calling for the Suffolk County Superior Court to grant an injunction so that he can have cannabis delivered to the island. “[Island Time] is being starved to death by the Commission’s arbitrary, unreasonable and inconsistent policy against transporting marijuana and marijuana products over state territorial waters,” Rose explained, warning that his employees will seek other jobs if his business is closed for two weeks or more. On May 9, the CCC met to discuss the situation and potential courses of action. Not only would the lack of delivery cause Island Time to close permanently, but it would also leave medical cannabis patients living on the island without any access to medicine. “If we do nothing, you are going to have 234 patients with no medical access on the Island. That’s the reality of it,” said commissioner Kimberly Roy. Additionally, local resident Sally Rizzo filed an affidavit with the supreme court as well. “If I have no retail source of marijuana for my medical needs, my quality of life will suffer significantly,” she wrote. “I am unwilling—and should not be compelled—to risk purchasing untested marijuana from the illicit black market or purchasing marijuana from the Massachusetts mainland and transporting it to my home via the Steamship Authority to treat my documented medical condition.”  The commission itself didn’t provide any comment to Vineyard Gazette due to ongoing litigation, and only verified what the current law allows or doesn’t allow. “At this time, transportation of marijuana from the Commonwealth mainland to the island counties is not one of those accommodations,” the CCC stated. “To the extent permitted by law, the Commission has been discussing what may be possible in terms of extending additional accommodations to these licensees and will be scheduling a public meeting on Martha’s Vineyard within the next month to continue the conversation.”However, there are examples of products being delivered in some other states, such as New York, where ferry delivery over water is still counted as “ground transport.” Similar rules are in place for the delivery of cannabis from mainland California to Catalina Island.

https://hightimes.com/

Loud Talking

On the industrial outskirts of Oakland, California, tucked among the timeworn facades of warehouses and workshops, there’s a building entrance so nondescript it defies capture by photography—not only would you never notice it if you walked right past it, you wouldn’t even be able to see it if you were looking directly at it. Security is a paramount concern for cannabis businesses operating in “The Town,” and thanks to a serendipitous quirk of forced perspective and pre-war architecture, would-be bandits would have an easier time robbing the Hogwarts Express. This is ideal for a business trying to prevent unwelcome visitors, but much less so for a visiting journalist with a faulty sense of direction and a penchant for getting stoned before big interviews. In addition to being monstrously difficult to locate, once you step inside the building housing the corporate headquarters for James Loud Genetics, it gives the distinct impression of being—to quote Doctor Who—“bigger on the inside.” Blazing white, labyrinthine hallways with soaring ceilings (accented with large television monitors displaying high definition photos of different stages of the germination and tissue culture processes) connect to specialized, climate-controlled lab rooms, processing centers, and the plush lounge that serves as the studio for the James Loud Podcast. The titular host of that podcast, James Loud, is the founder and primary breeder at James Loud Genetics, a cannabis brand with deep roots in the pre-legalization weed game. Loud cracked his first seed in 1995, at the age of 14, and never looked back. Since then, he’s been exploring the bleeding edge of breeding techniques and technology, always staying true to his name and seeking the same Holy Grail—louder terps. The son of an engineer, Loud’s process has always been rooted in experimentation and innovation, and in the early days of his breeding career—when police helicopters were still actively scanning for the telltale heat signature of a commercial indoor cannabis grow—he responded with a technological solution. “I had a garage grow and we grew in octagons,” Loud says. “So we had vertical growing because we were worried about the footprint for the infrared from the helicopter. So we thought the footprint would be less so the heat signature would be less. And so we grew in these vertical grows where we had 26 plants per light, and they all grew towards that center light.” With that problem more or less solved, he settled into the business of actually growing cannabis, with varying degrees of success at first. “I really like Chem Dawg, so I grew some and it was just this wall of larf, it was terrible… outdoor it was phenomenal, indoor it was phenomenal in beds, but it wasn’t meant to be grown in a vertical system with a short veg [period], because it likes to stretch… The best thing for the octagon was GDP because it has a very short veg, so you can take something like GDP and veg it for seven to 10 days max and it still wouldn’t get to the light.” Loud has made a lifelong career from cannabis breeding, a decision that has taken him on a decades-long personal and professional journey, with stops around the world, from Colombia to Spain and beyond, and it all began in the pages of High Times. Like many of us who discovered cannabis before the advent of the internet, Loud found information and inspiration in the pages of this very magazine. One year after smoking his first joint at the age of 14, he read something that changed the trajectory of his entire life. “There was a High Times article when I was younger called ‘The Million-Dollar Grow Room,’ and that was my favorite article growing up… it changed my perspective on growing. We had closet grows and stuff like that, but that article put things in the realm of financial possibility,” he says, then smiles a bit sheepishly and admits, “And I just love High Times.” It’s a sentiment that’s proven to be mutual. James Loud Genetics has secured six High Times Cannabis Cup victories and was inducted into the High Times Seed Bank Hall of Fame in 2014. “Now I want to do ‘The Billion-Dollar Grow Room, and you can only do that with seeds,” Loud says. “We can make a billion dollars with seeds, no problem.” Considering the facility’s current production rate of roughly seven million seeds per year, $1 billion in revenue doesn’t seem that farfetched. His decision to dive headfirst into the risky, unregulated world of clandestine cultivation immediately led him down the path of innovation and experimentation. And once again, High Times played a role in his journey. “I got the Phototron, you know the ones that were in the back of High Times magazine,” he says with a smile. “The first time we grew, one of my friends fucked it up, he poured a whole gallon of fish emulsion and made the weed taste like salmon.” But, of course, things got better. “From the moment I got green bud, I loved the taste, the smells, everything about it including the high,” he says. “I was into all the different flavors, and that’s what’s always motivated my breeding.” Loud is an experienced cannabis connoisseur, and as a breeder he’s all too familiar with the fickle winds of fashion—this year’s superstar strain is tomorrow’s forgotten fad. So it’s not terribly shocking that he’s a bit of a classicist when it comes to the cultivars he’s passionate about; you’ll often hear him talking about the big names of yesteryear, like Super Silver Haze and Romulan with deep reverence and love. But there’s one particular cultivar whose haunting siren song still echoes tantalizingly to him from a not so distant past, and his eyes glisten with the light of a secret flame when he speaks her name: Cat Piss. “That needs to be mentioned in the article, how much I love Cat Piss,” he says. “That’s my desert island strain… it’s super nostalgic, we got it in the ’90s, like mid ’90s.”  For Loud, it was the first cultivar he ever smoked that passed what would become one of his go-to tests for gauging just how “loud” some weed is, the re-fire test. “It’s the first thing that I really remember that you smoked it down to the roach, and you fired it up the next day or even a week later and it still tasted like Cat Piss,” he says. Younger readers—those of you acclimated to cannabis with the sweet, approachable cake and candy flavors that dominate the current terpene landscape—may not realize that us late 20th century smokers once sought out weed that smelled like animal excretions. Both Skunk and Cat Piss were once towering giants in the minds of stoners seeking the strongest strain, highly prized for the intense intoxicating effects that came along with their raw pungency. Skunk is undeniably the biggest name that emerged from that era; an amalgamation of three classic landrace cultivars; Acapulco Gold, Colombian Gold, and Afghani, that smelled just like its name. But if Skunk and its direct descendants are like The Beatles and The Rolling Stones—universally acclaimed, widely known, and indelibly linked to the era that produced them—Cat Piss is more like Grand Funk Railroad; equally popular during their shared heyday, but criminally underrated and less widely remembered in the present time. Loud is setting out to change all that with a project that sits at the intersection of three of his overlapping passions, cannabis breeding, cannabis education, and Cat Piss, a documentary film about his breeding project to resurrect the strain with assistance from the original breeder, which he says will film “this year with a goal of releasing it later in the year.” During the day of my visit he’s preparing to interview Steve DeAngelo—founder and former CEO of the pioneering cannabis dispensary Harborside—for yet another documentary project collecting the oral history of cannabis. This on top of his recently published book, a groundbreaking textbook on the technical nuances of cannabis breeding and tissue culture, Cannabis Breeding: The Art and Science of Crafting Distinctive Cultivars. Loud is building a cannabis media empire, and his aspirations are on full display in the slick, professional design of his podcasting studio lounge, which is where the majority of our meeting takes place. It has an elaborate paint job that includes a graffiti-style mural, a large, backlit sign with his logo on it, a wall of Mason jars filled with seeds, a professional array of condenser mics on telescopic stands arranged at a chic wooden conference table surrounded by comfortable office chairs, and a fully stocked bar with everything from Japanese whiskey to cold Imperial ale in the fridge. The show itself is a fun, informative space where drug war veterans swap stories and give each other their flowers (and/or concentrates) while they’re still alive. The vibe is casual but serious, because everyone involved takes the craft of cannabis cultivation very seriously, but they also tend to be very serious smokers and the James Loud Podcast studio is definitely the smoking section at this facility. The conversation is wide ranging, often personal, and always entertaining. It’s like Charlie Rose meets Joe Rogan, only instead of asking his guests if they’ve ever smoked DMT, Loud asks them if they’ve ever smoked Cat Piss. At a time when the outlaw past of this industry seems increasingly at odds with the hyper-regulated confines of its present and future, Loud provides a living bridge from past to present and a clear vision for the future. “We’re slowly but surely becoming tomato farmers,” he says. “The price has gone down. People will be able to make a good living doing it still—obviously there are very successful tomato farmers—but the high prices associated with the black market are mostly long gone.” The way he sees it, cannabis markets are simply maturing, the way all markets do. “With mature markets, you see people trusting brands,” he says. “In these unstable markets it’s all about the latest and greatest. I look at it like a Top 40 playlist and there’s not a lot of things that stand the test of time… I think in the future brand trust is going to be a much bigger thing, instead of the latest and greatest thing.” For Loud, that future is about using meristem tissue culture to secure clean, pathogen-free genetics and following his nose to the next facet of cannabis waiting to be expressed through purposeful breeding. And when it comes to all the new players in the weed game, the ones who never experienced the wild rush of the bad old days of total prohibition? Loud feels like anyone who would subject themselves to the very different challenges of the legal weed game—drug war veteran or not—is a warrior in their own right. He says his most recent visit to MJBizCon convinced him that the remaining players are all driven by passion, which he believes is the key ingredient to success. “They aren’t window shopping, they’re really invested in this industry,” he says. “There’s hardship, but the people sticking it out are really passionate about the plant and this is what they’d be doing even if they weren’t getting paid and that’s me, I’m that guy. I’m gonna be breeding no matter what, I’m gonna be smoking no matter what, because this is what I was meant to do.” This article was originally published in the May 2024 issue of High Times Magazine.

https://hightimes.com/

Sunset Connect Buys the Ticket, Takes the Ride

With a tagline featuring a founding year “Since before we could tell,” Sunset Connect alludes to the fluctuating legal status of the world’s most favored flower. When I visit the manufacturing space in San Francisco—a former lambskin condom factory and, later, a photography studio—the bright white walls are a welcome break from the dark gray day outside. It’s the last day of January 2024, and we’re in the middle of an atmospheric river called a “Pineapple Express,” but from founder Ali Jamalian’s upstairs office that oversees the space, I can only hear taps of the rain outside. Jamalian’s broad smile and kind eyes are the type that light up a room. Coupled with that, he’s a great storyteller. Through personal trials and triumphs, Jamalian has grown into a voice that remembers the outlaws of pot’s past. And, with his brand Sunset Connect, he’s proudly repping the profound legacy that San Francisco represents in shaping the availability of cannabis around the world. “You have to be an activist,” Jamalian says of operating a cannabis company in the City by the Bay. “You have to advocate for the industry.” Locals will first notice that Sunset Connect’s logo and branding borrow inspiration from Muni, San Francisco’s public transportation system, including buses, trains, and cable cars. The script on “Sunset”is in the same curving worm-like font as the iconic 1975 Muni logo. And, with packaging showcasing the design of paper Muni bus transfer tickets that were retired in 2016, its brand identity stands as a sort of insider call back to an earlier time. Sunset Connect has evolved over the years but is now putting out hash-infused dogwalkers and trim pre-rolls. The pre-rolls retail at $5. “I think what we really pride ourselves in is the separation, getting all the fan leaves and the sticks and stems out and really being left with sugar leaf and small buds,” Jamalian says as we walk the manufacturing floor. “My whole point was like, ‘Dude, you’ve got to be able to get something to people at a fair price that they can afford every day.’” Jamalian believes the batch size, 100 grams, is critical to the salability of his 1-gram pre-rolls and says he’s selling about 25,000 each week.  “We firmly believe that the success of our joints is that they’re hand-topped and twisted,” Jamalian says as I watch an employee complete packing the herb down and adding the wick-like twist of paper at the top. “I think that’s what gives you the good draw and the fact that we grind it in tiny batches of 100 grams.” Steered by hippies and activists who sold grass in the 1970s and provided cannabis to those in medical need in the 1990s, San Francisco stands as a significant touchpoint for the medical marijuana movement. Actions that took place there and in the greater San Francisco Bay Area led California to become the first state to approve medical marijuana in 1996. The Sunset Connect brand was born in California’s medical marijuana era and was granted a state license as a manufacturing and distribution company in the adult-use cannabis marketplace in 2020. Based in the city’s Sunset District and known as The Sunset Connect, Jamalian and his best friends since freshman year at the University of San Francisco brought cuts of classic strains to medical marijuana dispensaries circa 2014. This included White Widow—an extremely popular strain in the late ’90s and early 2000s following its win at the 1995 Cannabis Cup—and a strain breeders Mr. Sherbinski and Jigga created in a Sunset District garage around 2010, Sunset Sherbert. While the Sunset Connect team went official in 2014, they had been growing pot together for some time before that. Back in 1999, the feds charged Jamalian with possession and intent to distribute weed, and since he was a German-Iranian with a green card, he faced deportation. Spooked from the ordeal, he returned to Germany for a time and returned to the United States when his friends called him back into the game. “At that point, the boys were already blowing up like 15 houses in the Sunset and around town and doing really well with it, vending to dispensaries, but mostly moving it black market,” Jamalian says. “So I came back… I started with one house on 47th [avenue] and about two to three years later about four to five houses and then between us we had like 30-35 homes.” In 2018, when Jamalian started working to bring Sunset Connect into the adult-use cannabis marketplace, he began to get politically involved with organizations designed to advocate for the industry. But within those groups, such as the now-defunct California Growers Association, he says he often found business owners campaigning on behalf of their companies rather than the community. “Everyone that I worked with was moving weight and risking their lives to move weight,” Jamalian says. “And most of them didn’t get to transition…The heads in the Sunset weren’t being considered because we didn’t have warehouses; we had homes. Because back then, the criminal liability of growing at home was a lot less than the criminal liability of a 90-light warehouse.” His role as a public-facing cannabis grower took the next step when Jamalian connected with Jane Kim, a member of the San Francisco Board of Supervisors, who was running against acting mayor London Breed in 2018. “When I met Jane, I told her I was already trying to build this place up and go legal, and she’s like, ‘In this city, you have to become an activist,’” Jamalian says. “She really taught me the way around City Hall.” In January 2020, Jamalian became a member of the San Francisco Cannabis Oversight Committee, a representative group of cannabis company leaders that advise the board of supervisors and the mayor regarding implementing and enforcing city laws and regulations relating to cannabis. Beyond his political work, he’s always looking to network inside the cannabis community and puts on a monthly gathering in a Sunset District bar for budtenders. “I think building a community, not to sell your product, it gives people an emotional connection to your brand,” Jamalian says. “We were the underdog, and we still are, and I think people like to root for the underdog.” Kim’s cousin, Sam Joo, now works for Jamalian, handling compliance and production. Upon meeting him, Joo is locked in deep on the computer, navigating a change in California policy that vastly reduced the number of labs authorized by the state to test cannabis. When we chat about the current scene, he uses a phrase that became a touchpoint in describing California cannabis before its adult-use stage, the Wild West. “We don’t have a choice but to build our production around what the labs are capable of doing,” Joo says. “I guess the excuse is that it’s new. I don’t know if other industries have faced what the cannabis industry is facing, but it feels like the Wild West, you know, where nobody really knows what they’re doing.” The fluctuating nature of the regulations in the state’s adult-use cannabis industry has compounded with other factors, such as a dip in wholesale prices, in driving many longtime weed companies out of the market. Cannabis cultivators in California are disappearing in droves, and San Francisco is no exception to those statistics. Reporting done by the Cannabis Business Times in March 2023 shows that the state has lost thousands of cultivation licenses in recent years. Jamalian tells me he’s learned that surviving in the cannabis industry means you have to be willing to expand and contract. He is readying for his brand to grow and plans to cultivate and release flowers under the Sunset Connect brand again soon. With that anticipated launch, he’s bringing back Dosi-Pie, a Velvet Pie and Do-Si-Dos cross. It’s the strain he says the brand was most well-known for at dispensaries back in the day. Sunset Connect’s current version has a peppery spice on the nose and tastes how sandalwood incense smells. Now in his second term on the oversight committee, Jamalian uses his decades of experience in the city’s cannabis scene to advocate for the weed industry that remains in San Francisco. “The market is on a downward slope; there’s going to be 30% of brands who disappear,” he says. “People are looking for good flowers from San Francisco. Also, there’s not a lot of outfits here anymore producing really good flowers. “So, while San Francisco contracted, I think similar to the AI boom, cannabis companies are about to bloom again. Because the few that are left, they have a foot in the market, they’re now established, and people are like, ‘Wait, San Francisco is where the best weed in the world all comes from.’” This article was originally published in the May 2024 issue of High Times Magazine.

https://hightimes.com/

NOT TRAPPED: the Hesh take.

When you’re a minority and you say you work in cannabis, or with cannabis, everyone automatically thinks you’re trapping. Growing up I saw my dad go back and forth to prison for years. I never asked why or what he did; I just knew he went, and I was glad when he came home.  In May of 2007, when I was in 5th grade, he got out. He came to pick me up (from school?) in a red 2005 Chevy Cavalier that was filled with smoke. My 2 brothers were in the backseat. I would usually only see them during holidays, or visiting my grandma in prison. She was not there for weed. By then any stigma was gone, I was immune to it. I knew what it was forever because my mom and other family members frequently smoked it, but I had never seen an adult smoke like, right next to me, in plain sight—and while driving, at that. I remember asking him, “You can just smoke anywhere and everywhere?” He proceeded to pull out a laminated paper card and explain to my 11 year old self how he’s prescribed it, and that I needed to “stay in a fuckin’ kids place.” That was that. Needless to say I proceeded to watch him roll countless swishers, all while driving with his kneecap, on our way up to Hanford, California. The whole time we’re listening to his old cellmate Messy Marv on repeat. I knew this drive like the back of my hand from all those prison trips for my grandma, so I sat back and turned on my PSP to watch Lords of Dogtown while loads of PomPom smoke was being blown from my dad’s mouth, through the steering wheel, bouncing off the blowing AC vent, right into my face. By this point I was already familiar with smoking. I had tried it a couple of times at the skatepark with some older friends, so it’s not like he was giving me my first contact high or anything, but it was just around like that. Hours later, we finally pulled into the town home projects around 4 pm. My cousins and aunties immediately surrounded the four of us, greeting us all with hugs and handshakes. In the distance you could see my uncle Jamel run out of the house. Standing at about 6’3 and weighing probably 380 lbs, Jamel walks over to my dad, stinking of cheetos, ass, and stress weed. Completely out of breath he yells “PJ, I KNOW YOU BROUGHT THAT MEDICAL BOMB WITH YOU!” My dad quickly replied “Man this strawberry cough gon’ have you sleep in the toilet again, stop!”  Quick side piece: Apparently on a prior visit to Hanford the cops raided my auntie’s apartment. In their search of the spot they found Jamel asleep upstairs on the toilet, while my dad was in the garage with a woman half dressed explaining his medical condition to the police on the scene. He even showed them his legal medicinal cannabis license. You see, in 2007 it wasn’t as common for people to have a medicinal recommendation for cannabis as it is today. My auntie Danetta yelled out in the background “PJ, I’M GOING TO JAIL FOR WEED!!!!!” as my dad explained why the house constantly smelled like it to the head lead. Shortly after that the whole house was let out of their zip ties and handcuffs. Well, beside Jamel, who had a minor warrant out for his arrest.  Now back to my story. When we arrived this time I watched my dad pull out a duffle bag from the trunk of the car we drove up in and head into the garage, which was his normal post. Soon after, other cars filled up the alley, and I watched people leave happily after a brief meeting with my dad. Some had frowns on their faces, sometimes making different remarks about the price. But after seeing how stressed my dad was dealing with all this, I thought to myself: “I never wanna deal with this shit.”  Fast forward 17 years later, and now I find myself in certain places, like weed events, genuinely there just to have fun, and I get random people asking for my number, or direct messages from kids on social media asking for my telegram.  I do my best to laugh so they don’t see I’m either mad or confused. I tell them I just smoke it. Sometimes I do product development for my homies. I’m not in sales. On top of my short patience, I don’t really have customer service skills, and I already smoke a quarter pound myself in about 2-3 days, on average. I salute to all my pack shifters, ounce movers, and the craziest of the clientele server, the shake shaker. Honestly, if you have the patience (and time) to be a budtender, I salute you too, because that shit seems like it’s a hassle in itself!  I just think it’s funny being young and black in the weed game, because people be so surprised that I don’t care about what the rappers or celebrities are smoking. I’m far more interested in what Sourwavez, TrulyRedPanda, or LA Flav are dropping—or what Jon C is talking about.  I guess the point is, you look silly when I walk into a room and you think I want to “steal your custies.” In reality, I’m a “custie” myself. That worried look from dealers is always funny—or the snobby looks from growers who think I don’t know anything. That’s stereotypical shit, most of the time. But that look they get when my actual snobby weed friends come over and they see what time it is NEVER gets old.

https://hightimes.com/

Best THC Gummies: The Ultimate Guide to Euphoric Edibles

These THC-infused candies deliver a precise dosage per gummy, suitable for both experienced users and newcomers. Available in various options, including 25 mg Delta 9 THC gummies or those with a balanced THC and CBD mix, they cater to a spectrum of experiences. You can easily navigate the complexities of THC and CBD, ensuring an experience that caters to both recreational desires and therapeutic needs. Remember, the onset time can be around 30 minutes, so patience is key. Keep your gummies away from direct sunlight, and always review lab test results to ensure safety and potency. This comprehensive guide provides a list and review of the best THC gummies of 2024. You can select the most suitable gummy product from our list for effectiveness. Mystic Labs has a 9.8/10 rating for its exceptional THC gummies, with high customer satisfaction rates reflecting their commitment to quality, potency and service. Its top-selling gummies are praised for their great taste and consistent effects, underpinned by reliable shipping and return policies. The brand’s gummies are made with a full-spectrum formula, ensuring users benefit from the entourage effect of cannabinoids. They can indulge in a variety of flavors like Blood Orange, Goji Berry, and Savage Lime, each designed to enhance your THC experience. Esteemed platforms like High Times and Leafly vouch for their quality. The key features of the gummies include accurate THC dosage and suitability for new and seasoned users. Customer reviews on the official product page praise the gummies’ effectiveness and flavor. One said, “These do the trick for me. Relaxing and mellow.” General Disclaimer: Educating yourself about THC and its potential risks before using it is crucial. Follow the link here to find more information on this topic. Erth Wellness’s 9.7/10 rating reflects its dedication to customer satisfaction. It aims to provide safe, potent CBD and THC products. It’s quickly become a preferred source for premium gummies. Erth Wellness uses a broad-spectrum formula in the gummies, offering a rich cannabinoid experience without the psychoactive effects of THC, perfect for those seeking a non-intoxicating option. Its flavors, which include Pineapple Express and Strawberry Cough, and effectiveness have been reviewed positively on Weedmaps and CannaInsider. The product’s key features include adding natural ingredients, delicious fruity flavors, and a wide range of gummy options. Customer satisfaction is evident: “These gummies are game-changers,” said one user. Established in 2016, FabCBD offers potent, safe THC products. With a solid 9.5 out of 10, this brand excels in customer satisfaction thanks to its efficient shipping, hassle-free returns, and competitive prices. It collaborates with reputable hemp farms to guarantee quality, supported by customer-centric policies. The gummies boast a full-spectrum formula, providing a complete cannabinoid profile for enhanced effects. The formula is carefully made to ensure a high-quality, potent product. The gummies also come in two flavors: Guava and Melon. High Times and Leafly reviews confirm the brand’s commitment to excellence. Some of the key features of the gummies include the non-inclusion of GMO ingredients, third-party lab tests, constant THC dosage, and smooth effects. On the official product page, one customer said, “These gummies are a game-changer for relaxation!” Binoid exceeds expectations with an excellent 9.4/10 rating, thanks to exceptional THC gummies, customer service, and user-friendly policies. The brand specializes in high-quality THC products and has become a favorite among experienced users for its potent and flavorful offerings. Binoid offers full-spectrum CBD products, ensuring users experience the entourage effect. The formulations provide maximum efficacy and purity. The brand’s THC gummies come in various flavors to please every taste bud, but the Super 7 gummies are available in a Grape Cotton Candy flavor. The key features of the gummies include diverse flavor options, clean and safe production methods, and full-spectrum THC in all the gummies. HighTimes and Leafly have recognized Binoid for its excellence in the THC market. One customer review on the official Binoid product page states, “The effects are just what I was looking for!” Edobles earns a good 9.2/10 rating with its diverse product range, superior customer service, and competitive pricing. It offers a potent, flavorful range of gummies blending Delta 9, Delta 8, and HHC. The flavors include Mixed Berries and Sour Lemon. The THC gummies use only a full-spectrum formula, incorporating a range of cannabinoids to enhance the overall effect through the entourage effect. Some of the key features of the gummies include the non-inclusion of artificial ingredients, unique and natural flavors, and a consistent THC dosage. It is well-reviewed on High Times and Cannabis Culture for its effectiveness and taste. One customer raved on the official website, “The strawberry delta gummies not only taste great but also provide the perfect level of chill.” We evaluated each brand’s reputation, formula, and flavors to create this list of the best THC gummies. We also checked brands that have changed the game in THC gummies, considering customer reviews and comments across various platforms. The reputation of any brand or company can make or mar its relationship with existing and potential customers. Therefore, we carefully checked and picked only those with excellent reports. The formula for these gummies often includes citric acid, which adds a zesty tang and acts as a preservative. High-quality THC gummies also feature a balanced cannabinoid profile, essential oils, and natural flavorings to enhance the overall effect. THC gummies come in various mouthwatering flavors, ranging from tropical fruits to classic sweets. These flavors mask the natural earthiness of cannabis, making consumption a pleasurable experience. Users praise the consistent dosing that allows for a controlled experience, the quality of the high, and the delicious flavors. Negative comments tend to focus on taste preferences or dissatisfaction with the strength of effects, underscoring the subjective nature of cannabis edibles. THC gummies are a popular, inhalation-free option for experiencing THC’s benefits, suitable for various lifestyles and preferences. Users can better manage their intake and target specific ailments. The convenience and discretion of gummies make them suitable for various lifestyles and preferences. Whether you’re looking for relief, relaxation, or just a bit of euphoria, THC gummies could be a delightful addition to your wellness routine, provided they are used responsibly and by legal regulations. Related Topics: Best Delta 9 Gummies in 2024: Unveiling the World of THC Edibles Best Delta 8: The Ultimate Guide to Top Quality Products in 2024 Selecting the Best HHC Flower for the Essence and Benefits

https://hightimes.com/

Department of Justice Publishes Proposed Rule in Federal Register To Reclassify Cannabis

The federal government is finalizing the reclassification of cannabis. The U.S. Department of Justice published a proposed rule in the U.S. Federal Register to reclassify cannabis from Schedule I of the federal Controlled Substances Act (CSA) and move it to Schedule III. For over 50 years, cannabis has been classified as a Schedule I controlled substance, a classification reserved for drugs with “no medical value.” Many critics from the cannabis industry have criticized the reclassification, saying that only decriminalization is enough and that moving cannabis to Schedule III only puts it in a slightly less restrictive category. Then on Oct. 6, 2022, President Biden asked the Attorney General and the Secretary of Health and Human Services (HHS) to launch a review of how cannabis is classified. After receiving HHS’s recommendations last August, the Attorney General first sought legal advice from the Justice Department’s Office of Legal Counsel (OLC). Then, based on the HHS’ medical and scientific determinations, and OLC’s legal advice, the Attorney General exercised his authority under the law to initiate the rulemaking process to reclassify cannabis. The proposed rule was first announced by the DOJ Office of Public Affairs on May 16, and follows a series of recommendations and approvals. “The Department of Justice proposes to transfer marijuana from schedule I of the Controlled Substances Act (CSA) to schedule III of the CSA, consistent with the view of the Department of Health and Human Services (HHS) that marijuana has a currently accepted medical use as well as HHS’s views about marijuana’s abuse potential and level of physical or psychological dependence,” the proposal for the federal register reads. “The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing.” “If the transfer to schedule III is finalized, the regulatory controls applicable to schedule III controlled substances would apply, as appropriate, along with existing marijuana-specific requirements and any additional controls that might be implemented, including those that might be implemented to meet U.S. treaty obligations,” the proposal reads. “If marijuana is transferred into schedule III, the manufacture, distribution, dispensing, and possession of marijuana would remain subject to the applicable criminal prohibitions of the CSA. Any drugs containing a substance within the CSA’s definition of “marijuana” would also remain subject to the applicable prohibitions in the Federal Food, Drug, and Cosmetic Act (FDCA). DOJ is soliciting comments on this proposal.” The National Organization for the Reform of Marijuana Laws (NORML) offered cautious enthusiasm for change, finally at the federal level. “NORML is in a unique position to mobilize interested parties to provide their perspectives throughout the public comment period and we will be encouraging advocates and experts to do so in the coming weeks,” said NORML’s Deputy Director Paul Armentano. “In particular, it is important that the voices of both physicians and patients are heard and considered, as the Justice Department weighed the real-world experiences of doctors and their patients in medical cannabis states when making their recommendation to reclassify.” “Additionally, NORML will be submitting our own comprehensive comments substantiating the evidentiary record that cannabis possesses accepted medical utility and comparatively low dependence liability,” Armentano continued. “We will also be addressing a number of the issues raised by political opponents with respect to cannabis’ impact on public health, making it clear that these concerns do not warrant the continued classification of cannabis as a Schedule I substance. While NORML ultimately favors descheduling rather than rescheduling, we understand that reclassification is associated with both symbolic and tangible benefits to the cannabis community, both in the short-term and the long-term.” Now that the rule proposal has been published on the Federal Register, the public comment period will kick off and run for about 60 days.​​ The rescheduling of a controlled substance must undergo a formal rulemaking procedure that requires a notice to the public, informing them of an opportunity to comment and an administrative hearing. Then the DEA will gather and consider information and views submitted by the public, in order to make a determination. During that process, and until a final rule is published, marijuana remains a schedule I controlled substance. Comments must be submitted electronically or postmarked on or before July 22, 2024. Interested persons may file a request for a hearing or waiver of an opportunity for a hearing or to participate in a hearing pursuant to 21 CFR 1308.44 and in accordance with 21 CFR 1316.47 or 1316.49, as applicable, which must be received or postmarked on or before June 20, 2024. The DOJ encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Individuals can go to the regulations website and follow the online instructions at that site for submitting comments.

https://hightimes.com/

Leaked Photos Show Banksy at Work

Photos over 20 years old show the enigmatic artist known as Banksy at work, painting a 17-ton train car in Malaga, Spain that is now worth nearly $2 million dollars. Little did the artist know that a man who was talking to him took a photo and held on to it all these years. Gloucester Live reports that the never-before-seen photos of Banksy that emerged show the artist painting his biggest ever artwork. The train car was called The Turbozone Truck, it went up for auction with the starting price of £1 million ($1.27 million USD)  to £1.5m ($1.9 million USD) after it was authenticated by his studio. The photos also appear to be authentic as it is a well-known piece by the artist. “I used to spend a lot of time in Bristol,” the unidentified photographer said. “Our friends told us about this party that was going on in Spain and we thought why not? At the time we were very aware of Banksy’s stuff when it was popping up, but he was still quite under the radar.” The pictures were taken in the early hours of a New Year’s Day party in Malaga. At the time, they had no idea how big Banksy would eventually become after he blew up. “Then we were at the party and saw this guy painting—the three of us just turned to each other and said it’s got to be Banksy!” he said. “Little did we know at the time he would go on to become one of the most famous artists in the world.” The photographer then says he approached the man and asked him if he was the elusive street artist, and says the man confirmed he was Banksy.  “It wasn’t much of a conversation–-I remember we said how we’d seen some of his work in Bristol, as far as I remember, he had been flown over from Bristol.” The train car featuring Banksy’s artwork spent years traveling from Europe to South America as part of a tour for Turbozone’s Cinderella show. It is also featured in Banksy’s official book, Wall and Piece, which was published in 2006 and authenticated by the artist via his studio, Pest Control. The identity of Banksy has never been revealed officially, however a number of names have been linked with Banksy in the past: Robert Del Naja, Robin Gunningham, Art Attack’s Neil Buchanan. Gunningham is probably among the best theories for Banksy’s identity, BBC reports. Banksy’s former agent Steve Lazarides claimed to show the artist at work in a separate photo, although none of the images new or old show his face.  The enigma known only as Banksy re-entered the world of cannabis with a new permanent installation in a Toronto, Ontario-based dispensary in 2020. The unofficial king of guerrilla art—in the form of graffiti—left a breadcrumb trail of mystery throughout Europe and across the world through stark political messages and epigrams. But now, the vandal’s art can be appreciated by cannabis consumers who often share his political beliefs. Tokyo Smoke brand announced its new cannabis retail store in Toronto, Ontario—as well as its permanent installation of an exclusive Banksy collection of art. The collection will feature “never-before-seen” works from the artist, as well as other notable pieces from other artists. The store was armed with plexiglass dividers at the retail counter and reminders to observe social distancing. Tokyo Smoke, which is a subsidiary of Canopy Growth Corp., opened the new location on 21 Bloor St. E. and the property is wheelchair accessible.  The artist appears to favor hash resin, a common item found in the U.K. and Europe. In 2003, for instance, the artist illegally hung his own art at the esteemed Tate Britain—formerly called the National Gallery of British Art—in an act he said was inspired by cannabis resin. His self-hung piece was entitled, “Crimewatch UK Has Ruined the Countryside For All of Us,” and was placed next to a 19th century landscape. Like all of his public pieces, it carried a political message buried in dark humor. Each time a Banksy piece is spotted, the media loses their minds. Banksy’s famous piece “Rage Flower Thrower” depicted a Black Bloc-looking protester throwing a bouquet of flowers instead of a Molotov cocktail. The Rage Flower Thrower, however, has been marketed as “Weed Thrower” on T-shirts and other merchandise on Ebay. The artist is best known for “Girl With Balloon,” a stenciled graffiti painting in East London. In 2018, a “Girl With Balloon” print was auctioned off in London at Sotheby’s for £1.042 million—only to self-destruct moments later. It was one of the latest of Banksy’s antics that once again shocked the world.

https://hightimes.com/

New Assembly Bill in New York Seeks To Legalize Psilocybin Service Centers

New York legislation Assembly Bill 10375 was recently introduced by Assembly Health Committee Chair Amy Paulin and aims to legalize psilocybin service centers. If passed, the A10375 would amend public law “in relation to promoting the health and well-being of the citizens of the state of New York by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi,” the bill stated. It would also require that the Department of Health (DoH) take charge of regulations, which involves cultivator licenses and approving psilocybin service center facilities. It would also create a “Regulated Psilocybin Advisory Board” made up of 13 members to study federal laws and policies regarding psilocybin, and offer advice and recommendations to the DoH. The purposes of the board would be to “develop a long-term strategic plan for ensuring that psilocybin services in the state will become and remain a safe, accessible and affordable therapeutic option, including in therapeutic and medical treatments, for all persons eighteen years of age and older for whom psilocybin services may be appropriate.” Psilocybin business expenses would be tax deductible, and proceeds and fees would go back into the program to fund “administration and other costs relating to programs pursuant to this title, including but not limited to public education and risks of using psilocybin.” Currently there are 58 conditions that would qualify for a patient to utilize the services of a psilocybin center, which ranges from glaucoma, HIV/AIDS, migraines, multiple sclerosis, post-traumatic stress disorder, sleep disorders, treatment resistant depression, and so much more. Additionally, patients with other conditions not included in the initial list can also be considered for psilocybin therapy if it “has been identified in a study published in a medical or scientific journal.” In order for a patient to receive a permit for psilocybin therapy, they must first receive a health screening and complete a permit course. The bill wouldn’t legalize psilocybin, and consumption, cultivation, and sales would be prohibited. Violators would be hit with a $250 fine and a maximum of 15 days imprisonment. As of May 21, the bill has been sent to the Assembly Health Committee, of which Paulin is the chair. Other legislation involving psilocybin has led to promising progress. In February 2023, Assemblymember Pat Burke introduced Assembly Bill 03581, which would establish a psilocybin assisted therapy grant program and allow patients to engage in such treatments either in a licensed treatment center, or at home if the patient cannot travel. “This country is facing a mental health crisis,” Burke wrote on X last year. “I am looking at all options to alleviate the pain so many are feeling. Breakthrough medicines like psilocybin are showing tremendous benefit. I carry the bill to legalize psilocybin therapy. Let’s get it done!” In February 2024, Burke introduced Assembly Bill 08349 which would create a psilocybin  therapy pilot program for 10,000 veterans and first responders. “We’re in a mental health crisis, and so we need every tool that’s available to us,” Burke said. Meanwhile, the state’s legal cannabis industry continues to develop. In mid-April, the New York Cannabis Control Board approved 101 adult-use cannabis licenses. “With the Cannabis Control Board’s issuance of 101 adult-use cannabis licenses, New York’s legal cannabis industry continues to make significant progress with over 400 licenses issued in 2024,” Gov. Kathy Hochul said. “Strengthening New York’s equitable cannabis industry and ensuring the hard-working small business owners operating in the legal market have the licenses to open are the best way to protect the integrity of sales in New York.” As of late April, the state celebrated the opening of its 100th dispensary, called Big Gas, which opened through the help of the New York State Cannabis Investment Fund. “New York State continues to make progress on standing up a safe and legal cannabis industry for business owners, farmers and residents across the state,” said Hochul about the news. “Today marks a historic milestone in establishing a thriving and equitable industry in our state with the 100th brick-and-mortar store opening.” The topic of psilocybin continues to influence more illuminating research studies.  One such study which was published this month in the Journal of Psychoactive Drugs showed evidence that it won’t change a person’s belief as an atheist, agnostic, or believer in God. “These findings suggest that concerns that psychedelics could change metaphysical beliefs or result in ‘conversions’ across religious affiliations may be overestimated,” wrote researchers of their findings. They added that “concerns related to changes in non-naturalistic beliefs or religious affiliation may be exaggerated.” Other recent studies include a dive into psilocybin as a meditation enhancement, show evidence that psilocybin isn’t associated with paranoia risk, and proves that natural psilocybin has more therapeutic benefits in comparison to synthesized psilocybin. Another psilocybin treatment center recently opened up in Oregon, called Ashland Healing Center, which is also the first black-owned treatment center. Additionally, the Oregon Health Authority approved another psilocybin license to Kaya Holdings Inc., for a business called The Sacred Mushroom, which plans to open sometime in June.

https://hightimes.com/

Monitoring Weed’s Business Landscape

The Massachusetts Cannabis Control Commission (CCC) recently shared that the state collected $1.8 billion in cannabis sales during 2023. The figure reflects a combined total of recreational cannabis sales ($1.56 billion) and medical cannabis sales ($225 million). That’s a significant increase between total sales from 2022, which landed at a total of $1.49 billion ($1.42 billion for adult-use sales and $260.2 million for medical cannabis sales). “This continued growth confirms that Massachusetts’ regulated marijuana industry is still a maturing market,” CCC acting chair Ava Concepcion said in a press release. “As more retailers and delivery licensees come online, flower prices start to stabilize, and the stigma surrounding cannabis slowly dissipates—legal, tested products are becoming more accessible, affordable, and approachable than ever before, and that’s reflected in the multiple sales records licensees broke in 2023.” Sales from December 2023 showed the highest amount of sales collected for a single month at $140.1 million, surpassing the previously highest month for sales since August 2023. Massachusetts’s adult-use cannabis industry was approved by voters in November 2016, and sales first began in November 2018. Over time, the cost of cannabis flower has greatly decreased, with the CCC recording the price of an average ounce at $14.13 in December 2020 that dropped to $5.66 per ounce as of December 2023. In year-to-date milestone statistics for Massachusetts’s adult-use cannabis industry, which began in December 2018, it collected $1 billion in sales in October 2020, $2 billion in August 2021, $3 billion in April 2022, $4 billion in December 2022, and $5 billion in August 2023.  Ever since Michigan launched adult-use sales in December 2019, the state has become one of the fastest growing cannabis industries. Following the release of December 2023 sales data, the Michigan Cannabis Regulatory Agency (CRA) shared that the state collected a total of $3.06 billion in combined adult-use and medical cannabis sales in 2023, which is major growth compared to sales collected in 2022 ($2.3 billion in combined sales). CRA executive director, Brian Hanna, told WGVU Public Media that the continued success of Michigan’s adult-use cannabis industry is due to a few factors, including cannabis tourism. “We are a state that has an adult use program surrounded by states that don’t,” Hanna told the news outlet. He also added that based on the $3.06 billion from 2023 cannabis sales, that would equate to $305 per capita, or an average amount per person. Sales aren’t the only increase seen in the Michigan cannabis industry, as Hanna told Crain’s Detroit that there has been an increase in job opportunities as well.  “As we head into 2024, the CRA continues to focus on transparency and communication, working with stakeholders as the industry continues to grow,” said Hanna. “We’re committed to supporting Michigan’s cannabis licensees who currently employ over 35,000 employees, a 23% increase from December 2022.” Data published by the Oklahoma Medical Marijuana Authority (OMMA) on Feb. 1 in its monthly licensing report show a continued decrease in overall active cannabis business licenses, as well as patient numbers. While OMMA data from February 2023 shows that the state once had 11,974 active cannabis business licenses in total, that number has decreased to 8,025 licenses as of February 2024. This total includes 4,347 cultivator licenses, 2,293 dispensary licenses, 1,248 processor licenses, 98 transportation licenses, and 26 lab testing licenses. Oklahoma voters made it clear that they don’t want adult-use legalization when they rejected Oklahoma State Question 820 in March 2023, but February 2024 data shows that medical cannabis patient numbers are also dropping as well. In February 2023, Oklahoma had 369,468 active medical cannabis patient cardholders and 1,554 caregivers, and 2024 numbers reflect a decrease to 345,308 licensed patients and 1,304 caregivers. In response to significant oversaturation in the cannabis industry, Oklahoma Gov. Kevin Stitt signed House Bill 3208 in May 2022 to implement a moratorium on cannabis business licenses. The ban was extended in May 2023, and is currently set to last until at least August 2026. However, according to an OMMA-commissioned report called “Cannabis Public Policy Consulting” that was published in June 2023, Oklahoma still had 32 times more cannabis than necessary in order to meet the demand of approximately 355,000 medical cannabis patients (the OMMA’s patient number for that month). Both legal and illegal Canadian cannabis prices are nearly the same, according to a recent data revelation. A company called Deloitte, which offers audit, consulting, tax, and advisory services, alongside publication collaborator Neobi, recently published a report entitled “Clearing the Smoke—Insights into Canada’s Illicit Cannabis Market.” The research report evaluated 624 legal and 57 illegal online stores in Canada between May and June 2023. One of the study’s most notable observations included a flower price comparison from both legal and illegal stores—which stated that the price difference showed that illegal flower was only 20% cheaper. When reviewing varying flower prices between one gram and up to 28 grams, the average price from illegal cannabis was $6.24 per gram, compared to $7.96 per gram for flower in legal stores.  “The gap in prices has considerably narrowed since the last pricing comparison performed by Statistics Canada in Q4-2019, when illicit flower products were priced 55% lower, with the current average price at $5.73 per gram for the legal market—indicating that declining prices in the legal market may have contributed to more capture of the market,” authors of the report explained.  Other findings included how legal stores had fewer stock keeping unit (SKU) counts (538) compared to illegal websites (918). When examining the breakdown between product percentages, legal storefront inventory included 25.6% flower, 25% pre-rolls, 16.1% edibles, 13.1% extracts, 11.1% vapes, 6.6% beverages, 2.2% topicals, 0.3% seeds, and 0.0% for other psychedelics that are currently illegal. Illegal store inventory looks quite different though, with 36.9% of all inventory being flower, followed by 2.6% pre-rolls, 15% edibles, 32.7% extracts, 4.3% vapes, 0.5% beverages, 0.9% topicals, and 7.1% other psychedelics.

https://hightimes.com/

Study: Daily or Near-Daily Cannabis Users Outnumber Alcohol Users of Same Frequency

The rising prominence of regular cannabis use over alcohol use is nothing new.  We’ve witnessed myriad research in recent years showing that states with legal recreational cannabis see decreases in alcohol use, that Gen Z tends to prefer cannabis over alcohol and other reports noting that cannabis has consistently generated more tax revenue than alcohol and cigarettes in states like Colorado and Washington.  So it’s not necessarily a surprise that, for the first time, the number of Americans who use cannabis on a daily, or near-daily, basis has eclipsed those who drink alcohol at the same frequency. Associated Press first reported on the recent analysis of national survey data, finding that an estimated 17.7 million people reported daily or near-daily cannabis use, compared to 14.7 million daily or near-daily American drinkers. For comparison, 1992 was the low point for daily cannabis use as less than 1 million people at the time said they used cannabis every day. According to study author Jonathan Caulkins, who researches cannabis policy at Carnegie Mellon University, alcohol is still more widely used, but 2022 was the first time that the level of cannabis use overtook daily or near-daily drinking. “A good 40% of current cannabis users are using it daily or near daily, a pattern that is more associated with tobacco use than typical alcohol use,” Caulkins said. Caulkins’ study, titled “Changes in self-reported cannabis use in the United States from 1979 to 2022,” is based on data from the National Survey on Drug Use and Health and published in the journal Addiction on Wednesday. It notes that there was a 15-fold increase in the per capita rate of reporting daily or near-daily cannabis use from 1992 to 2022, whereas the 1992 survey found 10 times as many daily or near-daily alcohol users compared to cannabis users. Reflecting alcohol as the more commonly used substance, the study notes that the median drinker reported alcohol use on four to five days in the past month, versus 15 to 16 days of past-month use for cannabis users. Past-month cannabis consumers were almost four times as likely to report daily or near-daily use and 7.4 times more likely to report daily use, according to the study. Of course, this trend is no accident. It’s the product of gradual policy changes, advocacy and broader education surrounding the true nature of cannabis use and cannabis consumers following decades of skewed propaganda and harsh criminalization. The study notes four major periods of cannabis policy fluctuation in the U.S., starting with liberalization in the ‘70s as 11 states decriminalized or reduced cannabis-related penalties. This is alongside the Shafer Commission report, which countered the popular notion that cannabis users were dangerous, concluding that users tend to be more passive and cannabis does not cause widespread danger to society. It also recommended social measures to curb usage rather than criminalization. The more conservative policies of the 1980s and early ‘90s followed, with President Reagan and Bush Sr.’s now somewhat infamous War on Drugs in full force. The third major period outlined by the study spans 1993 to 2008, a period of “state-led liberalization” underscored by an increasing recognition of medical cannabis contrary to federal policy. Finally, we witness the period of “explicit non-interference by the federal government” starting in 2009, with Deputy Attorney General David Ogden’s memo prompting American attorneys not to focus “federal resources in your states on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana.” Just a few years later, Colorado and Washington became the first states to legalize adult-use cannabis. “There were myriad other changes at the local, state and federal level in both law and policy,” the study notes. “Change has been continual, so these epochs are just signposts, not the only moments of change.” For those who have tried cannabis and who use it routinely, this information may not come as much of a surprise. American attitudes around cannabis have shifted, with the majority routinely sharing they consider cannabis as a safer alternative that alcohol and cigarettes. Research is also increasingly finding a lack of “hangover” effects in cannabis users, showing no evidence of next-day effects following THC consumption. This, of course, acts in stark contrast to alcohol use, so those who use cannabis frequently arguably have fewer obstacles to navigate surrounding general day-to-day functions. In addition, research is increasingly finding that even chronic pot use has minimal effects on motivation. Regular cannabis use isn’t without its faults. The Associated Press report includes the perspective of University of Maryland School of Medicine psychiatry professor Dr. David A. Gorelick, who notes that high-frequency cannabis users are more likely to become addicted to cannabis. Gorelick was not involved in the original study. Some studies have also pointed to increased risk in heart problems among heavy cannabis users (though other studies have suggested the opposite).  There’s also been a recent influx in studies suggesting that cannabis use, especially surrounding high-potency products, produces greater risk in developing psychosis. While substance abuse disorders indeed carry psychiatric comorbidities, there is limited evidence surrounding how this relationship translates to the general population and how much substance use disorders are driven by such comorbidities.  A number of studies have combated that narrative with advocates often arguing that touting this relationship between cannabis use and psychosis is simply the newest iteration of “reefer madness” of past years. Of course, more research is needed to fully determine the health impacts of regular cannabis use — something that the upcoming Schedule III status of cannabis will likely aid in.  That said, regular alcohol use is known to affect how the brain works over time, damage the heart, increase risk of stroke and high blood pressure and weaken the immune system, leaving people more susceptible to illness. There’s also the toll it takes on the liver and pancreas and its potential to cause several types of cancer. While cannabis may not be perfect, even your standard “recreational” user is likely to cite a number of medical-specific benefits they enjoy from their use. Many regular cannabis users utilize it as a means to better wellness or to usher in specific symptom relief while also helping to provide a sense of ease and escape from their struggles.  All to say, research like this often affirms what those in the cannabis community have been saying for years. Perhaps society is finally beginning to catch up.

https://hightimes.com/

Brand Spotlight: Abstrax

When Abstrax started its recent research project, I doubt anyone could have imagined it would discover a whole new universe beneath our still-evolving knowledge of cannabis compounds. Now, they’ve released research suggesting how we understand how weed tastes or smells might just be the tip of the iceberg. Working with 710 Labs, SepSolve Analytical, and Markes International, the research team opened a portal into a world of rare and unseen flavor and aroma compounds in cannabis. Founded in California in 2017, the Abstrax team calls themselves pioneers in botanical flavor technology. Its main business is to provide terpene-driven flavor solutions for industries such as cannabis, beverage, and fragrance. By studying the complete chemical makeup of a cultivar, Abstrax goes through a rigorous process to map out, select, analyze, refine, formulate, optimize, test, reformulate, test, and package before offering companies the truest strain-specific flavors they can produce. It does so through its three divisions: tech, which researches and creates terpene blends for various markets; labs, which conducts botanical testing and offers extraction/analytical technologies; and hops, providing research, products, and services to the brewing sector. Using two-dimensional gas chromatography, a sophisticated separation technique that offers higher resolution than traditional chemical analysis, Abstrax was able to detect pockets of “hidden compounds,” which they believe have a significant impact on odor and can shape the course of how we classify or even shop for weed. Abstrax researchers published the results of their findings in a white paper posted on their website and in the peer-reviewed journal ACS Omega. The research points out that one of the main driving factors regarding how consumers choose cannabis has to do with THC percentages. The battle over whether something is better because it’s stronger has caused more than a few amazing strains to become lost to time. However, another key factor in what someone purchases is and has always been how something smells. Despite restrictions across many states on cracking open a jar and letting someone take a whiff, this obsession with smell has led to terpenes, or terps, becoming the second most important factor that the study identifies when consumers decide which cannabis to buy. Now, packaging lists the most dominant terpenes on the label and uses them as a guide to tell consumers what they can expect. Abstrax and the research team see this as a partial response to the modern pushback to the classic indica, sativa, and hybrid classification system we’ve leaned on up to this point. As the cannabis industry develops more modern ways of labeling and portraying the different varieties of cannabis, it’s looking for new terms to replace indica and sativa, and smell has emerged as a dowsing rod as competitions divide strains between candy, citrus, and gas. Much of the marketing focus on educating base-level consumers past sativa and indica has shifted toward trying to describe to shoppers what these aromatic compounds mean concerning the taste, smell, and psychoactive effects of a strain. It makes sense since, as the research points out, they appear in high amounts, making them a seemingly perfect identifier for classification. Contrastingly, the research asserts that we might be trading one generalization for another in our use of terpenes, pointing to an additional study—“The phytochemical diversity of commercial cannabis in the United States,” published in PLOS One in May 2022—which concluded that in the United States, all cannabis falls into one of three terpene-dominant categories: terpinolene/ß-myrcene, D-(+)-limonene/ß-caryophyllene, or ß-myrcene/pinene. The authors point out that through this system, strains with very different smells ended up in the same groups together. With its skunky, woody aroma, Dogwalker OG wound up next to Tropicana Cookies and Purple Punch, two cultivars with very contrasting smells. Meaning that you can’t always assume something will smell a certain way due to high percentages of certain terpenes. “Taken together, these results strongly suggest that while aroma is a key property in differentiating cannabis varieties and user preferences, the importance of terpenes appears to be overstated,” researchers wrote. The team concluded that terpenes had less of a correlation with the sought-after attributes of a lot of “exotic” cannabis strains and that it must be these alternate classes of compounds at work. The study identified a wide variety of aroma classes, each with diverse functionality, that are responsible for some of the most desirable aromatic qualities found in modern cannabis. Two such classes include tropical volatile sulfur compounds (VSCs), which are responsible for the citrus notes in Tropicana Cookies or Tangie, and heterocyclic compounds like indole and skatole, which produce the rich, intense scent in strains like GMO. They also identified a class of chemicals called flavorants that includes alcohols, ketones, and esters, that go beyond terpenes in affecting the smells and tastes of cannabis. Though found in small amounts, they believe these compounds play a major role by combining to create many of the diverse tastes in modern “exotic” strains like Apple Fritter or Zkittlez. “The discovery of these compounds will play a crucial role in validating cannabis’s authenticity and accurately classifying cannabis varieties in the future,” says Max Koby, CEO and co-founder of Abstrax. Koby also said that utilizing these previously undiscovered cannabis compounds would allow Abstrax to create “the most flavorful and authentic cannabis flavors,” which will elevate the level of the terpene blends and isolate it sells, but also benefit everyone in the space. Consumers can finally have a better toolkit to identify what flavors and feelings they enjoy most. Cultivators, breeders, and brands could someday use this knowledge to better understand which plant components drive these sweet fruit flavors versus the savory ones. “This research helps us better understand flavor in the cannabis experience, allowing us to better educate our customers and select phenos for our genetic library,” says research co-author Brad Melshenker, co-CEO of 710 Labs. One of the more exciting benefits that Abstrax identified for this research was its ability to provide a jumping-off point for researchers and packagers to discover the best way of preserving these specific compounds and provide cannabis with a better shelf life. With additional research planned, Abstrax has announced a partnership to create educational content that helps tell the story of the revelations brought about by its discoveries. Somebody reach out to Paul Rudd. Just like Antman explored and expanded upon the understanding of the microscopic quantum realm the technology employed here shows us there’s so much more happening inside the plant than we’ve ever imagined. Abstrax believes “we stand at the dawn of a new era in cannabis understanding” and that the microcosm of additional compounds inside these plants is part of a secret roadmap researchers are just now learning to draw. This new research will allow us to look for and provide solutions to many of the problems that have arisen from the swift evolution of cannabis from evil weed to essential service. Maybe someday, in a galaxy far, far, away, an android will extend a glass jar to smell the nugs instead of watching an image spin on a budtender’s holopad. This article was originally published in the February 2024 issue of High Times Magazine.

https://hightimes.com/

New Bill Would Remove Louisiana Universities’ Cannabis Cultivation Licenses

Since 2015, Louisiana State University (LSU) and Southern University (SU) are the only two public institutions in Louisiana that can legally cultivate medical cannabis. However, if Senate Bill 228 is signed into law, it would allow private contractors to take their place instead. “They are the only two higher education systems in the country that are in the pot business right now, and it is my belief that it’s time we get them out of that business and let them focus on higher education,” said Sen. Patrick McMath, who is also the sponsor of the bill, told the Louisiana Illuminator. Apparently, LSU and SU received help from two private growers, Good Day Farm and Ilera Holistic Healthcare, to get their own respective farms operational. If the bill becomes law, LSU and SU would transfer their respective cultivator licenses over to Good Day Farm and Ilera Holistic Healthcare, both of which will be permitted to hold on to their licenses for as long as they choose to renew them. As a result, no other cultivators would be allowed to apply for a license. According to Louisiana Illuminator, Good Day Farm in particular has a relationship with legislators who may be attempting to control all cultivation within the state. Good Day Farm’s primary shareholder is Donald “Boysie” Bollinger, one of the richest people in the state, and company president John Davis’ wife, Paula Davis, is a House representative. One of the key people who helped develop legislation for Louisiana’s medical cannabis law, former Rep. Joe Marino, told the news outlet that doing so would create a monopoly on cultivation.  During his time in office, Marino introduced legislation to expand the number of cultivation licenses available for application, although it didn’t pass. In 2022, he also worked to expand the number of cannabis pharmacies, from 10 to 25, which was signed by former Gov. John Bel Edwards. In March, McMath attended a committee hearing for SB-228, and claimed that the Louisiana medical cannabis industry was always meant to be private. He explained that including both LSU and SU was a late-hour floor amendment. “It was never really their intention to be put into this bill,” McMath said. An earlier draft of SB-228 would have still provided a percentage of gross sales from Good Day Farms and Ilera Holistic Healthcare to the universities, but that has since been removed. SB-228 was sent to Gov. Jeff Landry on May 16 for a signature or veto. There has been plenty of other cannabis legislation introduced in the most recent legislative session. The Louisiana legislature initially legalized hemp-based edibles containing delta-9-THC back in 2022, with the knowledge presented by former House Speaker Clay Schexnayder who said it would require a person to consume “tractor-trailer loads” for a person to get high from it. Senate Bill 237 attempts to limit the law, and would make it illegal to sell or manufacture any cannabis products containing THC unless it’s included in a license medical cannabis product. During a committee hearing on May 14, many business owners claimed that such a bill would eliminate the consumable hemp industry that has been built so far, as well as any jobs that have developed from its success. Louisiana Hemp Extractors owner Paige Melancon expressed his frustration about spending the last two years building up his business. “I feel like I’m being fired right now and I want you guys to come with me and fire my employees when we leave here, if you choose to do that,” Melancon said. Supporters of SB-237 such as lobbyist Gene Mills, president Louisiana Family Forum, also spoke about putting an end to consumable hemp products. “Our vision is to build a Louisiana where God is honored, life is respected, families flourish and liberties reign,” Mills said at the hearing. Most recently, SB-237 was heard on the House floor for debate on May 22. Conversely, House Bill 707 seeks to establish a regulatory framework for adult-use cannabis legalization, although it doesn’t outright legalize recreational cannabis. “This is a very simple bill,” said bill sponsor Rep. Edmond Jordan. “What it does…it is for the adult use of cannabis. It sets up the retail side with dispensaries and how we would do that.” If passed, it would permit adults over 21 to purchase one ounce of cannabis per day and pay $75 per year to cultivate up to six plants per adult, or 12 plants per household. House Bill 978 also would not legalize adult-use cannabis but sought to establish a foundation for legalization in the event that the federal government chose to legalize cannabis. “The bill does not legalize recreational marijuana,” said bill sponsor Rep. Candace Newell. “This is a regulation structure that I would like to see Louisiana put in place in preparation for having recreational marijuana legalized on the federal level or on the state level.” However, as of May 20 the bill was rejected in the House.

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.